A SARS-like coronavirus 2 (SARS-CoV-2) has caused a pandemic Coronavirus Disease 2019 (COVID-19) that killed more than 3.3 million people worldwide. Like the SARS-CoV, SARS-CoV-2 also employs a receptor-binding motif (RBM) of its spike protein to bind a host receptor, the angiotensin-converting enzyme 2 (ACE2), to gain entry. Currently, several mRNA or adenoviral vaccines encoding for the spike protein of SARS-CoV-2 are being used to boost antibodies capable of inhibiting spike-ACE2 interaction and viral entry. However, recent evidence has also suggested an anti-inflammatory effect of spike-reactive antibodies, suggesting that some SARS-CoV-2 spike-based vaccines may elicit protective antibodies capable of inhibiting GM-CSF production and COVID-19 progression.
【저자키워드】 SARS-CoV-2, antibody, GM-CSF, Spike protein, 【초록키워드】 COVID-19, coronavirus disease, antibodies, Coronavirus disease 2019, ACE2, Vaccine, pandemic, SARS-CoV, angiotensin-converting enzyme 2, viral entry, Spike protein, protective antibodies, mRNA, receptor-binding motif, boost, Protective antibody, Angiotensin-converting enzyme, Evidence, Interaction, angiotensin, COVID-19 progression, host receptor, anti-inflammatory effect, spike protein of SARS-CoV-2, spike-based vaccines, SARS-like coronavirus, Spike-based vaccine, caused, the spike protein, suggested, elicit, Like, inhibiting, RBM, 【제목키워드】 Spike-based vaccine,